Goleta, CA, United States of America

Jacek Ostrowski

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chimeros, Inc.. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacek Ostrowski. Retrieved from https://idiyas.com/inventor/jacek-ostrowski-x39b9t1g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacek Ostrowski: Innovator in Targeted Drug Delivery Systems

Introduction

Jacek Ostrowski is a notable inventor based in Goleta, California. He has made significant contributions to the field of medical technology, particularly in the treatment of B-cell malignancies. His innovative approach focuses on enhancing drug delivery systems to improve patient outcomes.

Latest Patents

Ostrowski holds a patent for "Compositions and methods for treating B-cell malignancies." This invention provides a targeted multi-layered drug delivery system designed for the effective delivery of cytotoxic agents specifically to B-cells. His work in this area represents a significant advancement in cancer treatment methodologies.

Career Highlights

Jacek Ostrowski is associated with Chimeros, Inc., a company dedicated to developing cutting-edge therapeutic solutions. His role at the company allows him to apply his expertise in drug delivery systems to real-world medical challenges.

Collaborations

Ostrowski has collaborated with notable colleagues, including Claude Geoffrey Davis and Miguel A De Los Rios. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Jacek Ostrowski's contributions to targeted drug delivery systems exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in the treatment of B-cell malignancies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…